Zydus Lifesciences has secured an exclusive licensing and supply agreement with the US-based Viwit Pharmaceuticals for two ...

The agreement includes the supply of gadobutrol injection, a generic version of Gadavist, and gadoterate meglumine injection, ...

The USFDA's inspection of the facility took place from April 15 to 23, 2024, uncovering significant breaches of CGMP ...

Tripathi has had a legal career spanning nearly eight years. Before joining Zydus in September 2023, he worked at telecom ...

Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking ...

Ahmedabad: Zydus Lifesciences Ltd., a global innovation driven healthcare company has announced that its wholly owned ...

SMC Global said that Zydus Life has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive ...

The US FDA has issued a warning letter to Zydus Lifesciences citing significant manufacturing lapses at its Gujarat-based ...

The US health regulator has pulled up Zydus Lifesciences for manufacturing lapses at its Gujarat-based plant.

Zydus' agreement with Viwit Pharmaceuticals covers the supply of gadobutrol and gadoterate meglumine injections, widely used ...

Usnoflast (ZYIL1) is a novel, oral small molecule NLRP3 inhibitor. Studies have demonstrated that Usnoflast is highly potent ...